Literature DB >> 25024792

Peritoneal metastases from renal cell carcinoma: Images in urology.

Marcos Orestes Gonçalves1, Tarik Benidir2, Bruna Olandoski Erbano1, Juliana Elizabeth Jung3, Murilo de Almeida Luz4.   

Abstract

Entities:  

Year:  2014        PMID： 25024792      PMCID： PMC4081253          DOI： 10.5489/cuaj.2067

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  5 in total

1.  Renal cell carcinoma presenting with diffuse peritoneal metastases: CT findings.

Authors:  V M Tartar; J P Heiken; B L McClennan
Journal:  J Comput Assist Tomogr       Date:  1991 May-Jun       Impact factor: 1.826

2.  Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.

Authors:  David F McDermott; Meredith M Regan; Joseph I Clark; Lawrence E Flaherty; Geoffery R Weiss; Theodore F Logan; John M Kirkwood; Michael S Gordon; Jeffrey A Sosman; Marc S Ernstoff; Christopher P G Tretter; Walter J Urba; John W Smith; Kim A Margolin; James W Mier; Jared A Gollob; Janice P Dutcher; Michael B Atkins
Journal:  J Clin Oncol       Date:  2005-01-01       Impact factor: 44.544

3.  Renal cell carcinoma: late recurrence in 2 cases.

Authors:  J L Ruiz; C Vera; G Server; J M Osca; F Boronat; J F Jimenez Cruz
Journal:  Eur Urol       Date:  1991       Impact factor: 20.096

4.  Renal cell carcinoma presenting as a large abdominal mass with an extensive peritoneal metastasis.

Authors:  N J Stavropoulos; C Deliveliotis; D Kouroupakis; M Demonakou; J Kastriotis; C Dimopoulos
Journal:  Urol Int       Date:  1995       Impact factor: 2.089

5.  Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial.

Authors:  R I Fisher; C A Coltman; J H Doroshow; A A Rayner; M J Hawkins; J W Mier; P Wiernik; J D McMannis; G R Weiss; K A Margolin
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.